715 FS118, a tetravalent bispecific antibody targeting LAG-3 and PD-L1, induces LAG-3 shedding resulting in receptor downregulation by T cells via a novel mechanism of action

Ítems similars

• 715 FS118, a tetravalent bispecific antibody targeting LAG-3 and PD-L1, induces LAG-3 shedding resulting in receptor downregulation by T cells via a novel mechanism of action
  per: Michelle Morrow, et al.
  Publicat: (2020-11-01)
• Bispecific antibodies targeting immunomodulatory checkpoints for cancer therapy
  per: Tiancheng Zhang, et al.
  Publicat: (2023-03-01)
• Retention of the Bub3 checkpoint protein on lagging chromosomes
  per: Martinez-Exposito, Maria J., et al.
  Publicat: (1999)
• PD-L1/LAG-3 bispecific antibody enhances tumor-specific immunity
  per: Haiping Jiang, et al.
  Publicat: (2021-01-01)
• 1187 Antibody-lectin bispecifics for glyco-immune checkpoint blockade
  per: Nicholas Riley, et al.
  Publicat: (2023-11-01)